Featured Publication Advancing Shared Goals Click here to read the full report Research Papers Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026 A novel home-based method for preparing suspensions of anti-TB drugs Academia and industry agreement on a feasibility tool for first‐time‐in‐human clinical trial units For the Press Press Contact: Jess Wiggs p | +1 646 616 8613 e | jessica.wiggs@tballiance.org View the 2022 Annual Report